Company profile
MitoRx Therapeutics
Developing new treatments to restore healthy mitochondrial metabolism in patients living with high-risk obesity.
- Industry
- Biotechnology Research
- Employees
- 16
- Headquarters
- Oxford, Oxfordshire
- Founded
- 2021
- LinkedIn followers
- 3,676
- Office locations
- 1
MitoRx Therapeutics company summary
MitoRx Therapeutics is a company in the Biotechnology Research industry, headquartered in Oxford, Oxfordshire, founded in 2021. On LinkedIn the company has around 16 employees and 3,676 followers. Its listed specialties include mitochondrial disease, neuromuscular disease, biotech, preclinical, drug discovery.
What technology does MitoRx Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About MitoRx Therapeutics
MitoRx is a biotech company targeting the restoration of healthy mitochondrial metabolism in high risk obesity. Our first-in-class small molecule asset, MTRX31, targets the elimination of ectopic fat from affected organs, in people with metabolically unhealthy obesity, by resetting mitochondrial function rather than suppressing appetite. This has the potential to deliver durable and higher quality weight loss with implications for lower risk of cardiovascular complications and other serious disease, as well as benefits for body composition and improved quality of life.
Specialties
Where is MitoRx Therapeutics located?
MitoRx Therapeutics lists 1 location.
Compare companies similar to MitoRx Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
MitoRx Therapeutics mitorxtherapeutics.com | Biotechnology Research | 16 | 2021 | Oxford, Oxfordshire |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about MitoRx Therapeutics
What does MitoRx Therapeutics do?
MitoRx is a biotech company targeting the restoration of healthy mitochondrial metabolism in high risk obesity. Our first-in-class small molecule asset, MTRX31, targets the elimination of ectopic fat from affected organs, in people with metabolically unhealthy obesity, by resetting mitochondrial function rather than suppressing appetite. This has the potential to deliver durable and higher quality weight loss with implications for lower risk of cardiovascular complications and other serious disease, as well as benefits for body composition and improved quality of life.
How many employees does MitoRx Therapeutics have?
MitoRx Therapeutics has around 16 employees on LinkedIn.
Where is MitoRx Therapeutics headquartered?
MitoRx Therapeutics is headquartered in Oxford, Oxfordshire.
When was MitoRx Therapeutics founded?
MitoRx Therapeutics was founded in 2021.
Build a lead list from companies like MitoRx Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.